deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT01987297

Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL

Combined Retinoic Acid,Arsenic Trioxide and Chemotherapy for Newly-diagnosed Acute Promyelocytic Leukemia: Chinese National Multi-center Randomized Study

Sponsor: First Affiliated Hospital of Guangxi Medical University

Updated 12 times since 2017 Last updated: Aug 15, 2019 Started: Jun 30, 2012 Primary completion: Dec 31, 2020 Completion: Dec 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Acute Promyelocytic Leukemia, this trial is ongoing. The trial is conducted by First Affiliated Hospital of Guangxi Medical University and has accumulated 12 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2019 · 15 months · monthly snapshotUnknown Status~Sep 2019 – ~Dec 2019 · 3 months · monthly snapshotActive Not Recruiting~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotActive Not Recruiting~Oct 2021 – ~Jul 2023 · 21 months · monthly snapshotUnknown Status~Jul 2023 – ~Oct 2023 · 3 months · monthly snapshotUnknown Status~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshotUnknown~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshotUnknown~Sep 2025 – present · 12 months · monthly snapshotUnknown

Change History

12 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown PHASE4

  2. Aug 2025 — Sep 2025 [monthly]

    Unknown PHASE4

  3. Sep 2024 — Aug 2025 [monthly]

    Unknown PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown StatusUnknown

  5. Oct 2023 — Jul 2024 [monthly]

    Unknown Status PHASE4

Show 7 earlier versions
  1. Jul 2023 — Oct 2023 [monthly]

    Unknown Status PHASE4

  2. Oct 2021 — Jul 2023 [monthly]

    Unknown Status PHASE4

    Status: Active Not RecruitingUnknown Status

  3. Jan 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE4

  4. Dec 2019 — Jan 2021 [monthly]

    Active Not Recruiting PHASE4

  5. Sep 2019 — Dec 2019 [monthly]

    Active Not Recruiting PHASE4

    Status: Unknown StatusActive Not Recruiting

  6. Jun 2018 — Sep 2019 [monthly]

    Unknown Status PHASE4

    Status: RecruitingUnknown Status

  7. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • First Affiliated Hospital of Guangxi Medical University
  • First Affiliated Hospital of Zhejiang University
  • First Affiliated Hospital, Sun Yat-Sen University
  • First Hospital of China Medical University
  • Guangdong Provincial People's Hospital
  • Institute of Hematology & Blood Diseases Hospital, China
  • Nanfang Hospital, Southern Medical University
  • Ningbo No. 1 Hospital
  • Peking University People's Hospital
  • Qilu Hospital of Shandong University
  • Shandong Provincial Hospital
  • Shanghai Jiao Tong University School of Medicine
  • Southwest Hospital, China
  • Tang-Du Hospital
  • The First Affiliated Hospital of Anhui Medical University
  • The First Affiliated Hospital of Soochow University
  • The First Affiliated Hospital with Nanjing Medical University
  • The Second Affiliated Hospital of Dalian Medical University
  • Tongji Hospital
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
  • Union hospital of Fujian Medical University
  • West China Hospital
Data source: Shanghai Jiao Tong University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations